INVO Fertility Inc IVF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.16
- Day Range
- $1.13–1.20
- 52-Week Range
- $1.13–169.60
- Bid/Ask
- $1.13 / $1.14
- Shares Outstanding
- 1.79M
- Market Cap
- $2.02M
- Volume/Avg
- 110,706 / 2M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.02
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 46
- Website
- https://www.invobioscience.com
Valuation
|
Metric
|
IVF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.15 |
Price/Sales | 0.02 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
IVF
|
|---|---|
Quick Ratio | 0.81 |
Current Ratio | 0.90 |
Interest Coverage | −7.12 |
Quick Ratio
IVF
Profitability
|
Metric
|
IVF
|
|---|---|
Return on Assets (Normalized) | −20.06% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −27.81% |
Return on Assets
IVF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|yThz!R | LOCK|hgd^> | $164B | |||
| Stryker Corp
SYK
| LOCK|?Qd<^c^ | LOCK|Fjr | $126B | |||
| Medtronic PLC
MDT
| LOCK|ZJ<&nF< | LOCK|lnvdS | $107B | |||
| Boston Scientific Corp
BSX
| LOCK|$hj&vH | LOCK|Sy&!y | $67B | |||
| Edwards Lifesciences Corp
EW
| LOCK|!$Tpm@# | LOCK|q?^r? | $53B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|M>mSzr? | LOCK|>v | $29B | |||
| DexCom Inc
DXCM
| LOCK|#!M$Jf<z | LOCK|<%Y! | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|Nc | LOCK|%$T | $27B | |||
| Steris PLC
STE
| LOCK|W??>&^ | LOCK|#CDz# | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|Xw%#$#BF | LOCK|^rK | $18B |
United States